删除 发表于 2025-3-25 06:11:43

Beta-Blocker Controversies,A meta-analysis (Lindholm et al. 2005) concluded that beta-blockers should not remain the first choice in the treatment of primary hypertension. Unfortunately, this analysis included randomized controlled trials (RCTs) with poor methodology.

火车车轮 发表于 2025-3-25 09:24:34

http://reply.papertrans.cn/23/2218/221756/221756_22.png

杀人 发表于 2025-3-25 12:40:00

http://reply.papertrans.cn/23/2218/221756/221756_23.png

narcotic 发表于 2025-3-25 18:39:18

Hypertension Controversies,This statement is printed on the front cover of The Lancet of October 29, 2005. It is surprising that this peer-reviewed journal would print such a misleading statement.

Clumsy 发表于 2025-3-25 22:24:56

Myocardial Infarction,Acute coronary syndrome is a life-threatening condition (see Fig. 11-1).

iodides 发表于 2025-3-26 00:56:54

Heart Failure,The world faces an epidemic of heart failure (HF). The plague of HF is common in developed and in developing countries.

Orthodontics 发表于 2025-3-26 07:35:07

http://reply.papertrans.cn/23/2218/221756/221756_27.png

离开 发表于 2025-3-26 12:31:28

http://reply.papertrans.cn/23/2218/221756/221756_28.png

神刊 发表于 2025-3-26 16:18:23

Antiplatelet Agents, Anticoagulants, Factor Xa Inhibitors, and Thrombin Inhibitors,Antiplatelet agents are used in virtually all patients with coronary heart disease (CHD). Aspirin, the pioneer hallmark agent, is of proven value for the management of:

airborne 发表于 2025-3-26 18:32:09

http://reply.papertrans.cn/23/2218/221756/221756_30.png
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Cardiac Drug Therapy; M. Gabriel Khan Book 2015Latest edition Springer Science+Business Media New York 2015 ACE Inhibitor.Antiplatelet.Bet